HCM
BDSX icon

Heights Capital Management’s Biodesix BDSX Stock Holding History

Heights Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,938
Closed -$567K – 150
2024
Q3 		$567K Buy
+15,938
New +$548K 0.42% 30

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return

Heights Capital Management's BDSX Position: Q4 2024 in Review

Heights Capital Management sold out of Biodesix (BDSX) in Q4 2024, closing a stake of 15,938 shares — an estimated $567K sold.

Heights Capital Management first reported a position in BDSX in Q3 2024 and held it in 1 quarter. The position peaked at $567K in Q3 2024. 58 funds tracked by Wall St. Rank hold BDSX as of Q4 2024.

  • Heights Capital Management reported no remaining Biodesix position as of Q4 2024 after selling out during the quarter.
  • Heights Capital Management sold 15,938 Biodesix shares in Q4 2024, an estimated $567K.
  • Heights Capital Management first reported a position in Biodesix in Q3 2024 and held it in 1 quarter.
  • Heights Capital Management's Biodesix position peaked at $567K in Q3 2024.
  • 58 funds tracked by Wall St. Rank held Biodesix as of Q4 2024.

Based on Heights Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.